Beside the potent activation of Env-specific B cells, the observed humoral immune responses in mice suggest that these L1-Env nanoparticles provide an attractive novel approach for combinatorial vaccines tackling two major sexually transmitted diseases. The gene discussed is ERVW-1; the disease is sexually transmitted disease.